The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 606-612

  Kadoglou, Nikolaos P E ^a   Lambadiari, Vaia ^b   Gastounioti, Aimilia ^c   Gkekas, Christos ^a   Giannakopoulos, Triantafyllos G ^a   Koulia, Katerina ^a   Maratou, Eirini ^b   Alepaki, Maria ^a   Kakisis, John ^a   Karakitsos, Petros ^a   Nikita, Konstantina S ^c   Dimitriadis, George ^b   Liapis, Christos D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adipokines; Carotid atherosclerosis; Omentin 1; Retinol binding protein 4; Stroke

Indexed keywords

ADIPOCYTOKINE; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMENTIN 1; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG; C REACTIVE PROTEIN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CORONARY ARTERY RECANALIZATION; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; INTERNAL CAROTID ARTERY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; BLOOD; CAROTID ARTERY DISEASE; ECHOGRAPHY; METABOLISM; PATHOLOGY;

C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CYTOKINES; GPI-LINKED PROTEINS; HUMANS; LECTINS; PLAQUE, ATHEROSCLEROTIC; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84919375905     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.957     Document Type: Article

References (39)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:188-197. American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
2. Mokin M., Dumont T.M., Kass-Hout T., Levy E.I. Carotid and vertebral artery disease. Prim Care 2013, 40:135-151.
3. Meier P., Knapp G., Tamhane U., Chaturvedi S., Gurm H.S. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials. BMJ 2010, 340:c467.
4. Golemati S., Gastounioti A., Nikita K.S. Toward novel noninvasive and low-cost markers for predicting strokes in asymptomatic carotid atherosclerosis: the role of ultrasound image analysis. IEEE Trans Biomed Eng (Special Issue on Grand Challenges in Engineering Life Sciences and Medicine) 2013, 60:652-658.
5. Christodoulou C.I., Pattichis C.S., Pantziaris M., Nicolaides A. Texture-based classification of atherosclerotic carotid plaques. IEEE Trans Med Imaging 2003, 22:902-912.
6. Businaro R., Tagliani A., Buttari B., Profumo E., Ippoliti F., Di Cristofano C., et al. Cellular and molecular players in the atherosclerotic plaque progression. Ann N Y Acad Sci 2012, 1262:134-141.
7. Kadoglou N.P., Gerasimidis T., Golemati S., Kapelouzou A., Karayannacos P.E., Liapis C.D. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. JVasc Surg 2008, 47:55-62.
8. Kadoglou N.P., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., Kostakis A., et al. Adipokines: a novel link between adiposity and carotid plaque vulnerability. Eur J Clin Invest 2012, 42:1278-1286.
9. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
10. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. NEngl J Med 2006, 354:2552-2563.
11. Sun Q., Kiernan U.A., Shi L., Phillips D.A., Kahn B.B., Hu F.B., et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation 2013, 127:1938-1947.
12. Mallat Z., Simon T., Benessiano J., Clément K., Taleb S., Wareham N.J., et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. JClin Endocrinol Metab 2009, 94:255-260.
13. Xiao Y., Xu A., Hui X., Zhou P., Li X., Zhong H., et al. Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes. PLoS One 2013, 8:e66607.
14. Jialal I., Devaraj S., Kaur H., Adams-Huet B., Bremer A.A. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. JClin Endocrinol Metab 2013, 98:E514-E517.
15. Onur I., Oz F., Yildiz S., Oflaz H., Sigirci S., Elitok A., et al. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology 2014, [in press].
16. Liu R., Wang X., Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 2011, 93:21-25.
17. Kwon T.G., Kim K.W., Park H.W., Jeong J.H., Kim K.Y., Bae J.H. Prevalence and significance of carotid plaques in patients with coronary atherosclerosis. Korean Circ J 2009, 39:317-321.
18. Liapis C.D., Bell P.R., Mikhailidis D., Sivenius J., Nicolaides A., Fernandes e Fernandes J., et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009, 37(Suppl.4):1-19. ESVS Guidelines Collaborators.
19. Grant E.G., Benson C.B., Moneta G.L., Alexandrov A.V., Baker J.D., Bluth E.I., et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003, 229:340-346.
20. Gastounioti A., Kolias V., Golemati S., Tsiaparas N.N., Matsakou A., Stoitsis J.S., et al. CAROTID - a web-based platform for optimal personalized management of atherosclerotic patients. Comput Methods Programs Biomed 2014, 114:183-193.
21. Gastounioti A., Golemati S., Nikita K.S. Computerized analysis of ultrasound images: potential associations between texture and motion properties of the diseased arterial wall 2012, IEEE Int Ultrasonics Symp Dresden, Germany.
22. Kadoglou N.P., Gerasimidis T., Moumtzouoglou A., Kapelouzou A., Sailer N., Fotiadis G., et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc Endovasc Surg 2008, 35:661-668.
23. Kim H.S., Cho K.I. Association of carotid artery parameters of atherosclerosis in coronary artery disease. JCardiovasc Ultrasound 2013, 21:72-80.
24. Dessein P.H., Tsang L., Norton G.R., Woodiwiss A.J., Solomon A. Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis. PLoS One 2014 Mar 20, 9:e92739.
25. Katsiki N., Athyros V.G., Karagiannis A., Mikhailidis D.P. Metabolic syndrome and non-cardiac vascular diseases: an update from human studies. Curr Pharm Des 2014, [in press].
26. Bobbert T., Raila J., Schwarz F., Mai K., Henze A., Pfeiffer A.F., et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213:549-551.
27. Rocha M., Bañuls C., Bellod L., Rovira-Llopis S., Morillas C., Solá E., et al. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients. PLoS One 2013, 8:e78670.
28. Mohapatra J., Sharma M., Acharya A., Pandya G., Chatterjee A., Balaraman R., et al. Retinol-binding protein 4: a possible role in cardiovascular complications. Br J Pharmacol 2011, 164:1939-1948.
29. von Eynatten M., Lepper P.M., Liu D., Lang K., Baumann M., Nawroth P.P., et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007, 50:1930-1937.
30. Huang G., Wang D., Khan U.I., Zeb I., Manson J.E., Miller V., et al. Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS Study. Cardiovasc Diabetol 2012, 11:52.
31. Ingelsson E., Sundström J., Melhus H., Michaëlsson K., Berne C., Vasan R.S., et al. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009, 206:239-244.
32. Aust G., Uptaite-Patapoviene M., Scholz M., Richter O., Rohm S., Blüher M. Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA). Clin Chim Acta 2011, 412:1195-1200.
33. Sengul E., Duygulu G., Dindar S., Bunul F. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Ren Fail 2013, 35:1089-1093.
34. Yoo H.J., Hwang S.Y., Hong H.C., Choi H.Y., Yang S.J., Seo J.A., et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011, 10:103.
35. Yamawaki H., Tsubaki N., Mukohda M., Okada M., Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010, 393:668-672.
36. Yamawaki H., Kuramoto J., Kameshima S., Usui T., Okada M., Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011, 408:339-343.
37. Xie H., Xie P.L., Wu X.P., Chen S.M., Zhou H.D., Yuan L.Q., et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res 2011, 92:296-306.
38. Kadoglou N.P.E., Tahmatzidis D.K., Giannakoulas C.K., Kapelouzou A., Gkontopoulos A., Parissis J., et al. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction - KOZANI STUDY. JCardiovasc Med 2014, [in press].
39. Zhong X., Zhang H.Y., Tan H., Zhou Y., Liu F.L., Chen F.Q., et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011, 32:873-878.